Evaluation in 3 Months Duration of Neointimal Coverage After Zotarolimus-Eluting Stent Implantation by Optical Coherence Tomography. The ENDEAVOR OCT Trial

JACC: Cardiovascular Interventions

Volumn 2, Issue 12, 2009, Pages 1240-1247

  Kim, Jung Sun ^a   Jang, Ik Kyung ^b   Fan, Chunyu ^a   Kim, Tae Hoon ^a   Kim, Jin Sun ^a   Park, Sang Min ^a   Choi, Eui Young ^a   Lee, Sang Hak ^a   Ko, Young Guk ^a   Choi, Donghoon ^a   Hong, Myeong Ki ^a   Jang, Yangsoo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

drug eluting stent; optical coherence; tomography; zotarolimus

Indexed keywords

ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; IMPLANTATION; INTIMA; INTRAVASCULAR ULTRASOUND; LATE STENT MALAPPOSITION; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; STENT THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; THROMBOSIS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 72149133094     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.10.006     Document Type: Article

References (25)

1. Babapulle M.N., Joseph L., Belisle P., Brophy J.M., and Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364 (2004) 583-591
2. Jeremias A., Sylvia B., Bridges J., et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109 (2004) 1930-1932
3. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
4. Farb A., Burke A.P., Kolodgie F.D., and Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-1706
5. Kandzari D.E., Leon M.B., Popma J.J., et al. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 2440-2447
6. Miyazawa A., Ako J., Hongo Y., et al. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. Am Heart J 155 (2008) 108-113
7. Awata M., Nanto S., Uematsu M., et al. Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents. J Am Coll Cardiol 52 (2008) 789-790
8. Guagliumi G., Musumeci G., Sirbu V., et al. A prospective, randomized, controlled study using optical coherence tomography to evaluate strut coverage of sirolimus-, paclitaxel-, and zotarolimus-eluting coronary stents in long lesions requiring overlapping. Paper presented at: Late Breaking Trials, Transcatheter Cardiovascular Therapeutics Annual Meeting. Washington, DC (October 14, 2008)
9. Takano M., Inami S., Jang I.K., et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 99 (2007) 1033-1038
10. Kim J.S., Jang I.K., Kim J.S., et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9 month follow up: comparison with sirolimus-eluting stents. Heart 95 (2009) 1907-1912
11. Tanigawa J., Barlis P., and Di Mario C. Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroInterv 3 (2007) 127-136
12. Kume T., Akasaka T., Kawamoto T., et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 97 (2006) 1713-1717
13. Cheneau E., Leborgne L., Mintz G.S., et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 108 (2003) 43-47
14. Sianos G., Papafaklis M.I., Daemen J., et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 50 (2007) 573-583
15. Wenaweser P., Daemen J., Zwahlen M., et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 52 (2008) 1134-1140
16. Matsumoto D., Shite J., Shinke T., et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28 (2007) 961-967
17. Xie Y., Takano M., Murakami D., et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am J Cardiol 102 (2008) 27-31
18. Jang I.K., Bouma B.E., Kang D.H., et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 39 (2002) 604-609
19. Kume T., Akasaka T., Kawamoto T., et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 152 (2006) 755.e1-755.e4
20. Weissman N.J., Koglin J., Cox D.A., et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1201-1205
21. Sousa J.E., Costa M.A., Sousa A.G., et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107 (2003) 381-383
22. Joner M., Nakazawa G., Finn A.V., et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 52 (2008) 333-342
23. Ako J., Morino Y., Honda Y., et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46 (2005) 1002-1005
24. Hong M.K., Mintz G.S., Lee C.W., et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
25. Tanabe K., Serruys P.W., Degertekin M., et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111 (2005) 900-905